Final rule 2026-08812
Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device
The Food and Drug Administration (FDA) is classifying the circulating tumor cell enrichment device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the circulating tumor cell enrichment device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-08812
- Published
- May 6, 2026
- Effective
- May 6, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 24343
Docket identifiers
- Docket No. FDA-2026-N-4643
CFR references
- Title 21, part 866